Healthcare Organizations Call for FDA Action on Compounding Regulations Amid GLP-1 Shortages
March 23, 2025 - 10:21
Today, the Obesity Action Coalition (OAC) and The Obesity Society (TOS) have taken a significant step by sending a letter to the U.S. Food and Drug Administration (FDA). This letter, supported by over 20 prominent organizations and providers from various sectors of healthcare, emphasizes the urgent need for the FDA to implement and enforce federal regulations concerning compounding practices.
The call to action comes in the wake of recent shortages of GLP-1 medications, which are crucial for the treatment of obesity and related conditions. These shortages have raised serious concerns about patient access to essential therapies. The coalition argues that without stricter oversight and regulation of compounded medications, patients may face continued disruptions in their treatment options.
Healthcare leaders are advocating for a timely response from the FDA to ensure that patients receive the medications they need without interruption, highlighting the importance of regulatory frameworks in safeguarding public health.
MORE NEWS
August 26, 2026 - 02:33
Faulkner University Awarded More Than $3 Million to Transform Rural Health Care Access and Workforce Development in AlabamaFaulkner University has secured more than $3 million in funding through Alabama`s Rural Health Transformation Program to expand medical services and train a new generation of health care workers...
August 25, 2026 - 13:39
Drug mix-up at Ascension impacts at least 4 surgeries, leaves 1 patient paralyzedHospital officials are working to determine how a contaminated anesthetic may have reached operating rooms, after at least four joint replacement procedures were impacted and one patient was left...
August 24, 2026 - 17:16
Alfalfa sprouts linked to food poisoning in 15 states, officials sayFederal health authorities have identified alfalfa sprouts as the likely source of a multi-state food poisoning outbreak that has now reached 15 states. The Centers for Disease Control and...
August 24, 2026 - 15:42
FDA digital health leader promises generative AI regulatory guidance is comingThe U.S. Food and Drug Administration is preparing to release formal guidance on how it will regulate generative artificial intelligence used in medical devices, according to Rick Abramson, the...